Kou; Buyu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kou; Buyu.The latest application filed is for "novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease".

Company Profile

5.8.11

Kou; Buyu - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of synthesizing pyrazine compounds Grant 11,168,086 - Hu , et al. November 9, 2	2021-11-09
Novel Heteroaryl Heterocyclyl Compounds For The Treatment Of Autoimmune Disease App 20210300947 - DEY; FABIAN ; et al.	2021-09-30
Carboxy Tetrahydropyrazolopyrazine Compounds For The Treatment Of Infectious Diseases App 20200181156 - Hu; Taishan ; et al.	2020-06-11
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20200062753 - Guo; Lei ; et al.	2020-02-27
Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseases Grant 10,562,905 - Hu , et al. Feb	2020-02-18
Novel Carboxy Tetrahydropyrazolopyrazine Compounds For The Treatment Of Infectious Diseases App 20190322670 - Hu; Taishan ; et al.	2019-10-24
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 10,428,069 - Guo , et al. October 1, 2	2019-10-01
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20180370969 - Guo; Lei ; et al.	2018-12-27
Novel Pyrazine Compounds For The Treatment Of Infectious Diseases App 20180334461 - Hu; Taishan ; et al.	2018-11-22
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 10,081,627 - Guo , et al. September 25, 2	2018-09-25
Pyrazine compounds for the treatment of infectious diseases Grant 9,890,167 - Hu , et al. February 13, 2	2018-02-13
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 9,758,530 - Guo , et al. September 12, 2	2017-09-12
Novel Pyrazine Compounds For The Treatment Of Infectious Diseases App 20160237090 - HU; Taishan ; et al.	2016-08-18
Novel 6-bridged Heteroaryldihydropyrimidines For The Treatment And Prophylaxis Of Hepatitis B Virus Infection App 20160122363 - Guo; Lei ; et al.	2016-05-05
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20160083383 - Guo; Lei ; et al.	2016-03-24
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 9,266,904 - Guo , et al. February 23, 2	2016-02-23
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 9,233,978 - Guo , et al. January 12, 2	2016-01-12
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20150252057 - Guo; Lei ; et al.	2015-09-10
Novel 6-bridged Heteroaryldihydropyrimidines For The Treatment And Prophylaxis Of Hepatitis B Virus Infection App 20140343032 - Guo; Lei ; et al.	2014-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.